Hyperandrogen enhances apoptosis of human ovarian granulosa cells via up-regulation and demethylation of PDCD4

References

• Rowe PJ, Comhaire FH, Hargreave TB, et al. WHO manual for the standardized investigation and diagnosis of the infertile couple. Cambridge, UK: Cambridge University Press; 1993.
   Google Scholar
• Knochenhauer ES, Key TJ, Kahsar MM, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metabo. 1998;83:3078–3082.
   PubMed Web of Science ®Google Scholar
• Solomon CG. The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks. Endocrinol Metab Clin North Am. 1999;28:247–263.
   PubMed Web of Science ®Google Scholar
• Norman RJ, Dewailly D, Legro RS, et al. Polycystic ovary syndrome. Lancet. 2007;370:685–697.
   PubMed Web of Science ®Google Scholar
• Jansen E, Laven JS, Dommerholt HB, et al. Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients. Mol Endocrinol. 2004;18:3050–3063.
   PubMed Web of Science ®Google Scholar
• Sen A, Hammes SR. Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function. Mol Endocrinol. 2010;24:1393–1403.
   PubMedGoogle Scholar
• Cataldo NA, Dumesic DA, Goldsmith PC, et al. Immunolocalization of Fas and Fas ligand in the ovaries of women with polycystic ovary syndrome: relationship to apoptosis. Hum Reprod. 2000;15:1889–1897.
   PubMed Web of Science ®Google Scholar
• Bas D, Abramovich D, Hernandez F, et al. Altered expression of Bcl-2 and Bax in follicles within dehydroepiandrosterone-induced polycystic ovaries in rats. Cell Biol Int. 2011;35:423–429.
   PubMed Web of Science ®Google Scholar
• Shibahara K, Asano M, Ishida Y, et al. Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene. 1995;166:297–301.
   PubMed Web of Science ®Google Scholar
• Lankat-Buttgereit B, Göke R. The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol Cell. 2009;101:309–317.
   PubMed Web of Science ®Google Scholar
• Lankat-Buttgereit B, Göke R. Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy? Biol Cell. 2003;95:515–519.
   PubMed Web of Science ®Google Scholar
• Qiu X, Dong S, Qiao F, et al. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma. Oncogene. 2013;32:3296–3305.
   PubMed Web of Science ®Google Scholar
• Ding L, Gao F, Zhang M, et al. Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome. Fertil Steril. 2016;105:1330–1337.
   PubMed Web of Science ®Google Scholar
• Gao F, Wang X, Zhu F, et al. PDCD4 gene silencing in gliomas is associated with 5'CpG island methylation and unfavourable prognosis. J Cell Mol Med. 2009;13:4257–4267.
   PubMed Web of Science ®Google Scholar
• Qu F, Wang FF, Yin R, et al. A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells. J Mol Med. 2012;90:911–923.
   PubMed Web of Science ®Google Scholar
• Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996;93:9821–9826.
   PubMed Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–47.
   PubMed Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25.
   Web of Science ®Google Scholar
• Pan JX, Zhang JY, Ke ZH, et al. Androgens as double-edged swords: induction and suppression of follicular development. Hormones. 2015;14:190–200.
   PubMedGoogle Scholar
• Zhang LH, Rodriguez H, Ohno S, et al. Serine phosphorylation of human P450c17 increases 17, 20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Proc Natl Acad Sci. 1995;92:10619–10623.
   PubMed Web of Science ®Google Scholar
• Liu S, Jiang JJ, Feng HL, et al. Evaluation of the immature human oocytes from unstimulated cycles in polycystic ovary syndrome patients using a novel scoring system. Fertil Steril. 2010;93:2202–2209.
   PubMed Web of Science ®Google Scholar
• Filali M, Frydman N, Belot MP, et al. Oocyte in-vitro maturation: BCL2 mRNA content in cumulus cells reflects oocyte competency. Reprod Biomed Online. 2009;19:4309.
   PubMedGoogle Scholar
• Zhang J, Zhu G, Wang X, et al. Apoptosis and expression of protein TRAIL in granulosa cells of rats with polycystic ovarian syndrome. J Huazhong Univ Sc Technol. 2007;27:311–314.
   PubMedGoogle Scholar
• Honnma H, Endo T, Henmi H, et al. Altered expression of Fas/Fas ligand/caspase 8 and membrane type 1-matrix metalloproteinase in atretic follicles within dehydroepiandrosterone-induced polycystic ovaries in rats. Apoptosis. 2006;11:1525–1533.
   PubMed Web of Science ®Google Scholar
• Jurisicova A, Latham KE, Casper RF, et al. Expression and regulation of genes associated with cell death during murine preimplantation embryo development. Mol Reprod Dev. 1998;51:243–253.
   PubMed Web of Science ®Google Scholar
• Hwang SK, Jin H, Kwon JT, et al. Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice. Gene Ther. 2007;14:1353–1361.
   PubMed Web of Science ®Google Scholar
• Wang P, Zhao H, Li T, et al. Hypomethylation of the LH/choriogonadotropin receptor promoter region is a potential mechanism underlying susceptibility to polycystic ovary syndrome. Endocrinology. 2014;155:1445–1452.
   PubMed Web of Science ®Google Scholar
• Sang Q, Li X, Wang H, et al. Quantitative methylation level of the EPHX1 promoter in peripheral blood DNA is associated with polycystic ovary syndrome. PLoS One. 2014;9:e88013.
   PubMed Web of Science ®Google Scholar
• Yu YY, Sun CX, Liu YK, et al. Promoter methylation of CYP19A1 gene in Chinese polycystic ovary syndrome patients. Gynecol Obstet Invest. 2013;76:209–213.
   PubMed Web of Science ®Google Scholar